Atlas Venture Fund XII, L.P. - Apr 1, 2022 Form 4 Insider Report for Aerovate Therapeutics, Inc. (AVTE)

Role
10%+ Owner
Signature
Atlas Venture Fund XII, L.P. By: Atlas Venture Associates XII, L.P., Its: General Partner By: Atlas Venture Associates XII, LLC, Its General Partner, By: /s/ Ommer Chohan
Stock symbol
AVTE
Transactions as of
Apr 1, 2022
Transactions value $
$0
Form type
4
Date filed
4/4/2022, 05:13 PM
Previous filing
Jan 11, 2022
Next filing
Jul 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTE Common Stock Other $0 -466K -15% $0.00 2.64M Apr 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a pro rata distribution, and not a purchase or sale of securities, by Atlas Venture Fund XII, L.P. ("Atlas Venture Fund XII") to its general partner and limited partners without additional consideration. This distribution was effected pursuant to a plan adopted by Atlas Venture Fund XII pursuant to Rule 10b5-1 on November 24, 2021.